MX2014009391A - Tableta de antiacido. - Google Patents

Tableta de antiacido.

Info

Publication number
MX2014009391A
MX2014009391A MX2014009391A MX2014009391A MX2014009391A MX 2014009391 A MX2014009391 A MX 2014009391A MX 2014009391 A MX2014009391 A MX 2014009391A MX 2014009391 A MX2014009391 A MX 2014009391A MX 2014009391 A MX2014009391 A MX 2014009391A
Authority
MX
Mexico
Prior art keywords
tablet
calcium carbonate
tablets
breath
weight
Prior art date
Application number
MX2014009391A
Other languages
English (en)
Spanish (es)
Inventor
Maria S Mirabile
Sandip G Shah
Original Assignee
Glaxosmithkline Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Llc filed Critical Glaxosmithkline Llc
Publication of MX2014009391A publication Critical patent/MX2014009391A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2014009391A 2012-02-02 2013-01-31 Tableta de antiacido. MX2014009391A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261594055P 2012-02-02 2012-02-02
PCT/US2013/024078 WO2013116477A1 (en) 2012-02-02 2013-01-31 Antacid tablet

Publications (1)

Publication Number Publication Date
MX2014009391A true MX2014009391A (es) 2014-08-27

Family

ID=48905820

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014009391A MX2014009391A (es) 2012-02-02 2013-01-31 Tableta de antiacido.

Country Status (12)

Country Link
US (1) US20140037759A1 (enExample)
EP (1) EP2809331A4 (enExample)
CN (1) CN104136033A (enExample)
AR (1) AR089857A1 (enExample)
BR (1) BR112014019155A8 (enExample)
CA (1) CA2863389A1 (enExample)
CO (1) CO7020922A2 (enExample)
HK (1) HK1201179A1 (enExample)
IN (1) IN2014DN06198A (enExample)
MX (1) MX2014009391A (enExample)
WO (1) WO2013116477A1 (enExample)
ZA (1) ZA201405354B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025222289A1 (en) * 2024-04-23 2025-10-30 Biovantek Calcium carbonate formulations and method of treatment of gastroesophageal reflux disease (gerd)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ243567A (en) * 1991-07-22 1995-04-27 Bristol Myers Squibb Co Pharmaceutical oral formulation of a dideoxy purine nucleoside comprising the nucleoside together with a water-insoluble antacid buffering composition
GB9825033D0 (en) * 1998-11-13 1999-01-13 Nycomed Pharma As Process
US6358526B1 (en) * 2000-08-16 2002-03-19 Rexall Sundown Method of making tablets and tablet compositions produced therefrom
WO2004064719A2 (en) * 2003-01-24 2004-08-05 State Of Israel, Ministry Of Agriculture Synergistic compositions and methods for potentiating anti-oxidative activity
WO2004073632A2 (en) * 2003-02-19 2004-09-02 Biovail Laboratories Inc. Rapid absorption selective 5-ht agonist formulations
UA95093C2 (uk) * 2005-12-07 2011-07-11 Нікомед Фарма Ас Спосіб одержання кальцієвмісної сполуки
AR061093A1 (es) * 2006-05-12 2008-08-06 Drug Tech Corp Composiciones de calcio

Also Published As

Publication number Publication date
CN104136033A (zh) 2014-11-05
EP2809331A4 (en) 2015-07-15
WO2013116477A1 (en) 2013-08-08
CO7020922A2 (es) 2014-08-11
ZA201405354B (en) 2015-11-25
BR112014019155A8 (pt) 2017-07-11
HK1201179A1 (en) 2015-08-28
AR089857A1 (es) 2014-09-24
BR112014019155A2 (enExample) 2017-06-20
EP2809331A1 (en) 2014-12-10
IN2014DN06198A (enExample) 2015-10-23
US20140037759A1 (en) 2014-02-06
CA2863389A1 (en) 2013-08-08

Similar Documents

Publication Publication Date Title
EP2308511B1 (en) Tablet quickly disintegrating in the oral cavity and method for producing the same
EP2635264B1 (en) Formulations comprising polyethylene glycol
PL181340B1 (pl) tabletki do gryzienia oraz sposób wytwarzania kompozycji terapeutycznejwitaminowo-wapniowej w jednolitej galenowej formie tabletki do gryzienia PL PL PL PL PL PL PL
US20020193355A1 (en) Therapeutic combination of vitamin and calcium in unitary galenic tablet form, a method of obtaining it, and the use thereof
CA2106215C (en) Ingestible pharmaceutical compositions for treating upper gastrointestinal tract distress
US20160228467A1 (en) Peg or peg block copolymer for treating colorectal cancer
ES2394456T3 (es) Composiciones farmacéuticas bucodispersables
RU2762754C2 (ru) Композиция для применения в предупреждении и/или лечении индуцированного онкологическим лечением мукозита полости рта и желудочно-кишечного тракта
WO2006002836A1 (de) Brausezusammensetzungen von einschlafmitteln
MX2008002488A (es) Formulaciones de dosis solida que contienen farmacos para la perdida de peso.
JP2006232675A (ja) 複合型口腔内溶解用固形製剤
MX2014009391A (es) Tableta de antiacido.
JP2009269858A (ja) サルポグレラート経口投与製剤
JP7385367B2 (ja) 口腔内崩壊錠
US8337887B2 (en) Rapidly disintegrating taste-masked tablet
WO2010067151A1 (en) Quick disintegrating taste masked composition
WO2026019379A1 (en) A pharmaceutical composition comprising vitamin b
Sayeed et al. Formulation and in vitro evaluation of mouth dissolving tablets of Carvedilol by direct compression methods
WO2025106972A1 (en) Tableted effervescing dental treatment composition, and methods
Gandh et al. Formulation and evaluation of orodispersible antacid tablet for geriatric patient
Kwatra et al. Comparison Of Collagen-Curcumin Blend (Collaper Rtu) With Intralesional Steroid Injections in Oral Submucous Fibrosis a Randomized, Open-Label Interventional Study.
RU2789054C2 (ru) Пероральная дозированная форма, содержащая наружное покрытие для быстрого высвобождения
AT12928U1 (de) Formulierungen
DE202010016235U1 (de) Formulierungen
IES86031Y1 (en) A solid formulation for oral administration comprising polyethylene glycol and mannitol